
GULLO FRANCESCA
- U03, Piano: 2, Stanza: 2027B
- U03, Piano: 3, Stanza: 3041
Pubblicazioni
Tzanoulinou, S., Astori, S., Grandi, L., Gullo, F., Kalusivikako, R., Rai, S., et al. (2026). Divergent Modulation of Dopaminergic Neurons by Hypocretin/Orexin Receptors 1 and 2 Shapes Dopaminergic Cell Activity and Socioemotional Behavior. BIOLOGICAL PSYCHIATRY, 100(7), 779-795 [10.1016/j.biopsych.2026.05.022]. Dettaglio
Serra, L., Nordin, A., Jonasson, M., Marenco, C., Rovelli, G., Diebels, A., et al. (2025). SOX2 and NR2F1 coordinate the gene expression program of the early postnatal visual thalamus. BIOLOGY OPEN, 14(8) [10.1242/bio.062014]. Dettaglio
D'Aloia, A., Molteni, L., Gullo, F., Bresciani, E., Artusa, V., Rizzi, L., et al. (2021). Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(6), 1-24 [10.3390/ijms22063054]. Dettaglio
Sambri, I., Massa, F., Gullo, F., Meneghini, S., Cassina, L., Carraro, M., et al. (2020). Impaired flickering of the permeability transition pore causes SPG7 spastic paraplegia. EBIOMEDICINE, 61 [10.1016/j.ebiom.2020.103050]. Dettaglio
Maestrelli, F., Landucci, E., Luca, E., Nerli, G., Bergonzi, M., Piazzini, V., et al. (2019). Niosomal formulation of a lipoyl-carnosine derivative targeting TRPA1 channels in brain. PHARMACEUTICS, 11(12) [10.3390/pharmaceutics11120669]. Dettaglio